• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷能通路在人类自身免疫性疾病中的作用。

The role of adenosinergic pathway in human autoimmune diseases.

作者信息

Dong Ke, Gao Zhao-Wei, Zhang Hui-Zhong

机构信息

Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

出版信息

Immunol Res. 2016 Dec;64(5-6):1133-1141. doi: 10.1007/s12026-016-8870-2.

DOI:10.1007/s12026-016-8870-2
PMID:27665459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5126201/
Abstract

Autoimmune diseases are characterized by the abnormal immune response against self-tissue, which are caused by the failure of nature immune homeostasis. Nature immune homeostasis represents the normal state of appropriate immune response to nonself-antigen and unresponsiveness to self-antigens. In normal situation, immune homeostasis is regulated by immunosuppressive signal and immunostimulating signal together. Accumulating data have demonstrated that the adenosinergic pathway played key roles in immune suppression and shield body from an excessive inflammatory response. The deficiency of adenosinergic pathway results in the imbalance between the pro- and anti-inflammatory activities. Thus, researchers pay much attention to the role of adenosinergic pathway in autoimmune diseases development. To date, accumulating data have suggested an important role of adenosinergic pathway-related molecules (i.e., CD39, CD73, ADA, adenosine receptors, etc.) in many types of human autoimmune diseases. More importantly, these findings have presented potential value of adenosinergic pathway analysis to be used for autoimmune diseases diagnosis, monitoring and treatment. In this review, we will provide a comprehensive description of the role of adenosinergic pathway in human autoimmune diseases.

摘要

自身免疫性疾病的特征是针对自身组织的异常免疫反应,这是由天然免疫稳态失衡引起的。天然免疫稳态代表了对非自身抗原产生适当免疫反应以及对自身抗原无反应的正常状态。在正常情况下,免疫稳态由免疫抑制信号和免疫刺激信号共同调节。越来越多的数据表明,腺苷能途径在免疫抑制以及保护机体免受过度炎症反应方面发挥着关键作用。腺苷能途径的缺陷会导致促炎和抗炎活性之间的失衡。因此,研究人员非常关注腺苷能途径在自身免疫性疾病发展中的作用。迄今为止,越来越多的数据表明腺苷能途径相关分子(即CD39、CD73、ADA、腺苷受体等)在多种人类自身免疫性疾病中具有重要作用。更重要的是,这些发现显示了腺苷能途径分析在自身免疫性疾病诊断、监测和治疗方面的潜在价值。在本综述中,我们将全面描述腺苷能途径在人类自身免疫性疾病中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/284e/5126201/c90447a21e13/12026_2016_8870_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/284e/5126201/c90447a21e13/12026_2016_8870_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/284e/5126201/c90447a21e13/12026_2016_8870_Fig1_HTML.jpg

相似文献

1
The role of adenosinergic pathway in human autoimmune diseases.腺苷能通路在人类自身免疫性疾病中的作用。
Immunol Res. 2016 Dec;64(5-6):1133-1141. doi: 10.1007/s12026-016-8870-2.
2
The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases.细胞外腺苷生成在自身免疫性疾病发展中的作用。
Mediators Inflamm. 2018 Mar 26;2018:7019398. doi: 10.1155/2018/7019398. eCollection 2018.
3
Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.细胞外酶 CD39 和 CD73 的协同作用导致人恶性脑胶质瘤中的腺苷能免疫抑制。
Neuro Oncol. 2013 Sep;15(9):1160-72. doi: 10.1093/neuonc/not067. Epub 2013 Jun 4.
4
The role of the CD39-CD73-adenosine pathway in liver disease.CD39-CD73-腺苷通路在肝脏疾病中的作用。
J Cell Physiol. 2021 Feb;236(2):851-862. doi: 10.1002/jcp.29932. Epub 2020 Jul 10.
5
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.ADA 缺陷性 SCID 中腺苷代谢和 CD39/CD73 腺苷能机制的改变导致 Treg 细胞功能丧失和自身免疫。
Blood. 2012 Feb 9;119(6):1428-39. doi: 10.1182/blood-2011-07-366781. Epub 2011 Dec 19.
6
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.将细胞外 ATP 转化为腺苷:肾脏健康与疾病的主开关。
Nat Rev Nephrol. 2020 Sep;16(9):509-524. doi: 10.1038/s41581-020-0304-7. Epub 2020 Jul 8.
7
A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance.心脏发生过程中的缺氧事件会下调腺苷能系统并改变心肌的缺氧耐受性。
Am J Physiol Regul Integr Comp Physiol. 2015 Apr 1;308(7):R614-26. doi: 10.1152/ajpregu.00423.2014. Epub 2015 Jan 28.
8
The adenosinergic system: a potential player in the pathogenesis of ANCA-associated vasculitis?腺苷能系统:在抗中性粒细胞胞质抗体相关性血管炎发病机制中的潜在作用?
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):143-151. Epub 2018 May 3.
9
Regulation of the T Cell Response by CD39.CD39对T细胞反应的调控
Trends Immunol. 2016 Jul;37(7):427-439. doi: 10.1016/j.it.2016.04.009. Epub 2016 May 25.
10
CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.T细胞分化中的CD73和CD39外核苷酸酶:超越免疫抑制
FEBS Lett. 2015 Nov 14;589(22):3454-60. doi: 10.1016/j.febslet.2015.07.027. Epub 2015 Jul 29.

引用本文的文献

1
ATP stimulates appetite by enhancing the expression of hypothalamic orexigenic neuropeptides.三磷酸腺苷(ATP)通过增强下丘脑促食欲神经肽的表达来刺激食欲。
Mol Brain. 2025 Jun 10;18(1):49. doi: 10.1186/s13041-025-01220-y.
2
Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications.自身免疫性疾病中与年龄相关的B细胞:发病机制及临床意义
Clin Rev Allergy Immunol. 2025 Feb 17;68(1):18. doi: 10.1007/s12016-025-09021-w.
3
Causal association between plasma metabolites and diverse autoimmune diseases: a two-sample bidirectional mendelian randomization study.

本文引用的文献

1
Immune modulation for autoimmune disorders: evolution of therapeutics.自身免疫性疾病的免疫调节:治疗方法的演变
Semin Hematol. 2016 Apr;53 Suppl 1:S23-6. doi: 10.1053/j.seminhematol.2016.04.008. Epub 2016 Apr 6.
2
CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.CD39介导的Th17细胞效应功能调节在青少年自身免疫性肝病中受损。
J Autoimmun. 2016 Aug;72:102-12. doi: 10.1016/j.jaut.2016.05.005. Epub 2016 May 20.
3
Autoimmune disease: Conceptual history and contributions of ocular immunology.
血浆代谢物与多种自身免疫性疾病之间的因果关联:两样本双向孟德尔随机化研究。
Front Immunol. 2024 Nov 7;15:1437688. doi: 10.3389/fimmu.2024.1437688. eCollection 2024.
4
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer.CRISPR/Cas9介导的CD73基因敲除对胰腺癌的影响。
Cancers (Basel). 2023 Oct 3;15(19):4842. doi: 10.3390/cancers15194842.
5
Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73).人浆细胞样树突状细胞表达功能性嘌呤能晕 (CD39/CD73)。
Purinergic Signal. 2024 Feb;20(1):73-82. doi: 10.1007/s11302-023-09940-3. Epub 2023 Apr 14.
6
A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients.一种腺苷受体激动剂可降低健康 M2 样巨噬细胞中 MMP8 的表达,但不能降低强直性脊柱炎患者巨噬细胞中 MMP8 的表达。
BMC Musculoskelet Disord. 2022 Oct 12;23(1):908. doi: 10.1186/s12891-022-05846-0.
7
Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles.1型糖尿病和多发性硬化症中的红细胞及其新兴作用的测量技术。
J Transl Autoimmun. 2022 Aug 7;5:100161. doi: 10.1016/j.jtauto.2022.100161. eCollection 2022.
8
Purinergic modulation of the immune response to infections.嘌呤能调制感染免疫应答。
Purinergic Signal. 2022 Mar;18(1):93-113. doi: 10.1007/s11302-021-09838-y. Epub 2022 Jan 8.
9
Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity.人 CD73 的单 ADP-核糖基化位点抑制其生成腺苷的酶活性。
Purinergic Signal. 2022 Mar;18(1):115-121. doi: 10.1007/s11302-021-09832-4. Epub 2021 Dec 27.
10
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression.CD8 T 细胞来源的细胞外囊泡通过 CD73 介导的腺苷产生构成了免疫抑制的固有机制。
Nat Commun. 2021 Oct 8;12(1):5911. doi: 10.1038/s41467-021-26134-w.
自身免疫性疾病:概念史及眼免疫学的贡献
Surv Ophthalmol. 2016 Sep-Oct;61(5):680-8. doi: 10.1016/j.survophthal.2016.04.006. Epub 2016 Apr 27.
4
Clearance of rapid adenosine release is regulated by nucleoside transporters and metabolism.快速腺苷释放的清除受核苷转运体和代谢的调节。
Pharmacol Res Perspect. 2015 Nov 16;3(6):e00189. doi: 10.1002/prp2.189. eCollection 2015 Dec.
5
CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis.γδ T细胞上表达的CD73塑造其在实验性自身免疫性葡萄膜炎中的调节作用。
PLoS One. 2016 Feb 26;11(2):e0150078. doi: 10.1371/journal.pone.0150078. eCollection 2016.
6
The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis.A3腺苷受体(A3AR):类风湿关节炎的治疗靶点及预测性生物标志物
Clin Rheumatol. 2016 Sep;35(9):2359-62. doi: 10.1007/s10067-016-3202-4. Epub 2016 Feb 17.
7
Serum Adenosine Deaminase as Inflammatory Marker in Rheumatoid Arthritis.血清腺苷脱氨酶作为类风湿关节炎的炎症标志物
J Clin Diagn Res. 2015 Sep;9(9):BC08-10. doi: 10.7860/JCDR/2015/14296.6483. Epub 2015 Sep 1.
8
The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.间充质干细胞对人类系统性红斑狼疮中Treg/Th17平衡的调节作用
Cell Mol Immunol. 2017 May;14(5):423-431. doi: 10.1038/cmi.2015.89. Epub 2015 Oct 5.
9
An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation.一种 A2B 腺苷受体激动剂通过激活树突状细胞促进实验性自身免疫性葡萄膜炎(EAU)中的 Th17 自身免疫反应。
PLoS One. 2015 Jul 6;10(7):e0132348. doi: 10.1371/journal.pone.0132348. eCollection 2015.
10
Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.外切5'-核苷酸酶/CD73在内源性腺苷生成中的缺陷会损害实验性自身免疫性重症肌无力中的神经肌肉传递和免疫能力。
Mediators Inflamm. 2015;2015:460610. doi: 10.1155/2015/460610. Epub 2015 Jan 27.